Dark

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Apr 17, 2026 3:59:57 PM EDT

52.78USD+0.399%(+0.21)3,948,782

0.00Bid 0.00Ask 0.00Spread

Pre-market

Apr 15, 2026 9:18:30 AM EDT

52.63USD+0.114%(+0.06)0

After-hours

Apr 17, 2026 4:00:30 PM EDT

52.78USD0.000%(0.00)525

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.73B

CEO

Anish Bhatnagar

Headquarters

Redwood City, California, USA

Industry

Biotechnology

Next Earnings

May 6, 2026 (18d)

Last Split

Aug 26, 20221for15reverse

NEOG CEMI NYMX NTRP XLV

SLNO Stats

Avg. Vol. 10 Day

12,033,789

Avg. Vol. 30 Day

5,238,998

Employees

Market Cap

2,729,166,723

Shares Out.

51,718,149

On/Off Exchange

54%/46%

6 Month Beta

1.35

1 Year Beta

0.95

2 Year Beta

1.02

3 Year Beta

-0.10

52 Week Low

29.43

52 Week High

90.32

SMA50

40.07

SMA200

55.82

1 Week

+0.27%

1 Month

+60.88%

3 Month

+20.67%

6 Month

-19.40%

1 Year

-24.59%

2 Year

+42.05%

5 Year

+198.14%

Profile

soleno therapeutics, inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. the company is currently advancing its lead candidate, dccr, a once-daily oral tablet for the treatment of pws, into a phase iii clinical development program in early 2018.

SLNO Stock Summary

Soleno Therapeutics, Inc. Common Stock (NASDAQ:SLNO) stock price today is $52.78, and today's volume is 3,948,782. SLNO is up 0.399% today. The 30 day average volume is 5,238,998. SLNO market cap is 2.73B with 51,718,149 shares outstanding.

.dark-mode .hRlJHg{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .hRlJHg{ color: #333333; background-color: white; border: 2px solid #333333; }SLNOSoleno Therapeutics, Inc. Common Stockstock NASDAQ

SLNO Stock Summary

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ